A competitor’s patent may de­scribe a tech­nol­o­gy that looks un­com­fort­ably close to your prod­uct. That alone does not es­tab­lish li­a­bil­i­ty. The prac­ti­cal ques­tion is what makes a patent in­fringed: whether a prod­uct, process, or com­mer­cial act falls with­in the legal­ly con­strued scope of at least one en­force­able patent claim in the rel­e­vant country.

For founders and tech­ni­cal teams, this dis­tinc­tion mat­ters. Prod­uct sim­i­lar­i­ty can jus­ti­fy con­cern, but in­fringe­ment analy­sis re­quires a dis­ci­plined com­par­i­son be­tween claim lan­guage and tech­ni­cal facts. A sin­gle miss­ing claim fea­ture can be de­ci­sive. Equal­ly, a fea­ture that ap­pears ab­sent at first sight may still cre­ate risk where the claim is in­ter­pret­ed more broad­ly than expected.

What makes a patent in­fringed un­der the claims?

A patent is not in­fringed sim­ply be­cause some­one has used the same gen­er­al idea, achieved the same re­sult, or built a more ad­vanced ver­sion of a known prod­uct. The le­gal bound­ary is set by its claims. Each in­de­pen­dent claim de­fines a com­bi­na­tion of tech­ni­cal fea­tures that must be as­sessed against the ac­cused prod­uct or process.

The start­ing point is usu­al­ly straight­for­ward: iden­ti­fy an en­force­able claim and map every re­quired fea­ture to the prod­uct, method, soft­ware op­er­a­tion, man­u­fac­tur­ing step, or com­po­nent un­der re­view. If all re­quired fea­tures are present, in­fringe­ment may arise. If one re­quired fea­ture is gen­uine­ly ab­sent, lit­er­al in­fringe­ment of that claim will usu­al­ly fail.

Con­sid­er a claim re­quir­ing a sen­sor, a proces­sor con­fig­ured to cal­cu­late a spec­i­fied val­ue, and a dis­play that presents the re­sult in a par­tic­u­lar way. A de­vice con­tain­ing a sen­sor and proces­sor may still avoid the claim if it does not per­form the re­quired cal­cu­la­tion or lacks the de­fined dis­play func­tion. Con­verse­ly, a prod­uct team should not as­sume that chang­ing a component’s la­bel, form fac­tor, or in­ter­nal ar­chi­tec­ture avoids risk if it con­tin­ues to per­form the claimed tech­ni­cal function.

This is why a prop­er claim chart is more use­ful than a high-lev­el patent sum­ma­ry. It forces the analy­sis to an­swer a clear ques­tion for each lim­i­ta­tion: where, pre­cise­ly, is this fea­ture found in the prod­uct or process? Tech­ni­cal doc­u­men­ta­tion, source code, cir­cuit di­a­grams, test data, mar­ket­ing ma­te­r­i­al, user man­u­als, and phys­i­cal in­spec­tion may all be rel­e­vant evidence.

Claim in­ter­pre­ta­tion comes be­fore comparison

Claims are read through the eyes of the skilled per­son, us­ing the patent spec­i­fi­ca­tion and com­mon tech­ni­cal knowl­edge to un­der­stand their mean­ing. The word­ing mat­ters, but the analy­sis is not al­ways a nar­row dic­tio­nary exercise.

In the UK and oth­er Eu­ro­pean con­texts, courts as­sess what the skilled read­er would un­der­stand the patent to mean. In cer­tain cas­es, a vari­ant that does not fall with­in the or­di­nary mean­ing of the words may nev­er­the­less be treat­ed as in­fring­ing if it achieves sub­stan­tial­ly the same re­sult in sub­stan­tial­ly the same way and the vari­a­tion would not be re­gard­ed as ma­te­r­i­al by the skilled per­son. The pre­cise ap­proach de­pends on ju­ris­dic­tion and the facts.

That cre­ates a com­mer­cial­ly sig­nif­i­cant trade-off. A de­sign-around that is tech­ni­cal­ly dif­fer­ent may re­duce risk, but a su­per­fi­cial sub­sti­tu­tion may not. The more cen­tral the sub­sti­tut­ed fea­ture is to the in­ven­tion, the more care­ful­ly the al­ter­na­tive should be as­sessed and documented.

The acts that can amount to patent infringement

In­fringe­ment is not lim­it­ed to mak­ing a prod­uct. In the UK, an en­force­able patent can gen­er­al­ly be in­fringed by mak­ing, dis­pos­ing of, of­fer­ing to dis­pose of, us­ing, im­port­ing, or keep­ing a patent­ed prod­uct for those pur­pos­es with­out con­sent. Us­ing a patent­ed process, or deal­ing in a prod­uct ob­tained di­rect­ly from that process, can also cre­ate exposure.

The com­mer­cial act mat­ters as much as the tech­nol­o­gy. A busi­ness may face risk be­fore its first sale if it im­ports stock, of­fers the prod­uct for sale, or uses a patent­ed man­u­fac­tur­ing method. Demon­stra­tors, pi­lot in­stal­la­tions, and con­tract-man­u­fac­tur­ing arrange­ments should there­fore be con­sid­ered with­in the review.

There can also be in­di­rect in­fringe­ment. This may arise where a par­ty sup­plies or of­fers to sup­ply means re­lat­ing to an es­sen­tial el­e­ment of the in­ven­tion, know­ing — or where it is ob­vi­ous — that those means are suit­able and in­tend­ed to put the in­ven­tion into ef­fect in the UK. Com­po­nents with sub­stan­tial non-in­fring­ing uses re­quire a more fact-spe­cif­ic as­sess­ment. The supplier’s knowl­edge, in­tend­ed use, cus­tomer in­struc­tions, and the na­ture of the com­po­nent can be­come central.

A use­ful dis­tinc­tion is be­tween pri­vate ex­per­i­men­ta­tion and com­mer­cial ac­tiv­i­ty. Some statu­to­ry ex­cep­tions may ap­ply in lim­it­ed cir­cum­stances, in­clud­ing cer­tain ex­per­i­men­tal uses. They are not a safe as­sump­tion for prod­uct de­vel­op­ment, com­mer­cial tri­als, or mar­ket en­try. The scope of any ex­cep­tion should be re­viewed against the planned ac­tiv­i­ty, not re­lied upon as a gen­er­al com­fort statement.

A patent must be en­force­able in the rel­e­vant territory

Patent rights are ter­ri­to­r­i­al. A UK patent does not au­to­mat­i­cal­ly pre­vent man­u­fac­ture in Ger­many, sales in France, or use in the Unit­ed States. Eu­ro­pean patent pro­tec­tion also needs care­ful at­ten­tion: a Eu­ro­pean patent is not one uni­tary right in every re­spect, and the rel­e­vant val­i­dat­ed na­tion­al rights, Uni­tary Patent cov­er­age where ap­plic­a­ble, and court frame­work must be identified.

The first prac­ti­cal ques­tions are there­fore where the prod­uct is made, as­sem­bled, test­ed, stored, im­port­ed, sold, and used. For a con­nect­ed prod­uct, the analy­sis may also need to con­sid­er where rel­e­vant sys­tem steps oc­cur. For a process claim, the place of per­for­mance and the move­ment of prod­ucts di­rect­ly ob­tained by the process can be critical.

Tim­ing mat­ters as well. A pub­lished patent ap­pli­ca­tion can cre­ate com­mer­cial un­cer­tain­ty, but en­force­able rights and avail­able reme­dies de­pend on its le­gal sta­tus, ju­ris­dic­tion, and the ap­plic­a­ble rules. An ex­pired patent can­not be in­fringed through fu­ture acts, while a lapsed patent may some­times be re­stored. Patent reg­is­ters, re­new­al sta­tus, own­er­ship records, and claim amend­ments should be checked rather than assumed.

Va­lid­i­ty and in­fringe­ment are dif­fer­ent questions

A claim can be tech­ni­cal­ly rel­e­vant to your prod­uct and still be vul­ner­a­ble to in­va­lid­i­ty. Pri­or art may show that the claimed in­ven­tion was not new or in­ven­tive. The claim may be in­suf­fi­cient­ly dis­closed, added mat­ter may be an is­sue, or an amend­ment may have nar­rowed or al­tered the en­force­able scope.

How­ev­er, a po­ten­tial in­va­lid­i­ty ar­gu­ment is not the same as com­mer­cial free­dom to op­er­ate. Un­til a court or com­pe­tent au­thor­i­ty re­vokes or lim­its the patent, an ap­par­ent­ly weak patent can still be as­sert­ed and can still dis­rupt a launch, in­vest­ment round, sup­ply agree­ment, or ac­qui­si­tion. A de­fen­si­ble po­si­tion re­quires both sides of the analy­sis: does the claim cov­er the planned ac­tiv­i­ty, and how like­ly is the claim to with­stand challenge?

This is also why prod­uct teams should avoid treat­ing a favourable pri­or-art search as a com­plete in­fringe­ment an­swer. Pri­or art in­forms va­lid­i­ty. In­fringe­ment de­pends on the claims as they stand and the ac­tu­al prod­uct or process.

Ev­i­dence de­ter­mines the strength of the position

An al­le­ga­tion be­comes com­mer­cial­ly se­ri­ous when it is sup­port­ed by ev­i­dence of use. For an ex­ter­nal prod­uct, pub­licly avail­able ma­te­ri­als may show only part of the tech­ni­cal pic­ture. A patent own­er may rely on prod­uct sam­ples, re­verse en­gi­neer­ing, user doc­u­men­ta­tion, reg­u­la­to­ry fil­ings, man­u­als, pub­lic demon­stra­tions, or dis­clo­sures made dur­ing sales discussions.

For your own prod­uct, pre­serve a clear tech­ni­cal record. De­sign spec­i­fi­ca­tions, ver­sion his­to­ries, de­vel­op­ment de­ci­sions, test pro­to­cols, sup­pli­er com­mu­ni­ca­tions, and man­u­fac­tur­ing records can es­tab­lish what the prod­uct does, when it did it, and why a par­tic­u­lar de­sign choice was made. This ev­i­dence is valu­able whether you are as­sess­ing ex­po­sure, re­spond­ing to an al­le­ga­tion, or demon­strat­ing that a pro­posed de­sign-around has been implemented.

Con­fi­den­tial­i­ty de­serves equal care. A re­quest for tech­ni­cal in­for­ma­tion from a com­peti­tor, cus­tomer, or dis­trib­u­tor may have strate­gic im­pli­ca­tions. Pro­vide no un­nec­es­sary ad­mis­sions or in­com­plete tech­ni­cal ex­pla­na­tions be­fore the patent po­si­tion and com­mu­ni­ca­tion strat­e­gy have been assessed.

How to as­sess risk be­fore it be­comes a dispute

The right re­view is pro­por­tion­ate to the com­mer­cial de­ci­sion. A broad free­dom-to-op­er­ate study may be ap­pro­pri­ate be­fore en­ter­ing a new mar­ket or com­mit­ting to tool­ing. A fo­cused in­fringe­ment analy­sis may be more ef­fec­tive where a com­peti­tor has iden­ti­fied a par­tic­u­lar patent. In both cas­es, the work should be­gin with a pre­cise prod­uct de­f­i­n­i­tion, rel­e­vant ter­ri­to­ries, in­tend­ed acts, and a re­al­is­tic launch timetable.

A struc­tured analy­sis nor­mal­ly iden­ti­fies the patents most like­ly to mat­ter, con­firms their sta­tus and own­er­ship, con­strues the rel­e­vant claims, and maps those claims to the avail­able tech­ni­cal ev­i­dence. The out­come should not mere­ly say “high” or “low” risk. It should ex­plain the de­ci­sive fea­tures, the ev­i­dence gaps, the pos­si­ble de­sign changes, and the op­tions for li­cens­ing, op­po­si­tion, in­va­lid­i­ty work, or con­trolled mar­ket entry.

TIPAG de­liv­ers this type of tech­ni­cal patent analy­sis with the en­gi­neer­ing de­tail need­ed for com­mer­cial de­ci­sions. Where le­gal rep­re­sen­ta­tion or for­mal pro­ceed­ings are re­quired, in­de­pen­dent patent at­tor­neys can be in­volved while the tech­ni­cal ev­i­dence and claim map­ping re­main tight­ly managed.

The most use­ful time to ask whether a patent is in­fringed is be­fore a de­sign is frozen, tool­ing is or­dered, or a launch promise is made. A clear claim-by-claim as­sess­ment gives your team room to choose: change the prod­uct, chal­lenge the right, seek per­mis­sion, or pro­ceed with ev­i­dence-based confidence.